Expansion will create new opportunities for highly skilled technology talent, strengthen Edinburgh's position as a hub for healthcare innovation and accelerate technology that helps providers deliver exceptional care.

1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.

The fund builds on a 2024 round which unlocked more than £5.3m of investment.